524156 — TCM Income Statement
0.000.00%
Last trade - 00:00- IN₹305.55m
- IN₹399.53m
- IN₹260.06m
- 10
- 39
- 38
- 16
Annual income statement for TCM, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | Interim Report | ARS | ARS | PRESS |
| Standards: | IAS | — | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 42.5 | 35.5 | 73.5 | 322 | 260 |
| Cost of Revenue | |||||
| Gross Profit | 23.7 | 9.49 | 15.4 | 89.8 | 78.2 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 51.8 | 103 | 114 | 348 | 285 |
| Operating Profit | -9.27 | -67.6 | -40.5 | -25.4 | -25.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 3.07 | -58.8 | -43 | -22.5 | 13.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1.18 | -58.8 | -42.7 | -22.9 | 14 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 1.18 | -51.4 | -40 | -19.5 | 16.1 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.18 | -51.4 | -40 | -19.5 | 16.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.348 | -6.35 | -5.97 | -2.91 | 2.16 |